Neurology Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Association of Cardiovascular Health With Brain Age Estimated Using Machine Learning Methods in Middle-Aged and Older Adults 2024
• Blood pressure, antihypertensive use, and late-life Alzheimer and non-Alzheimer dementia risk. An individual participant data meta-analysis 2024
• Screening for Cognitive Decline in Isolated/Idiopathic REM Sleep Behavior Disorder 2024
• Physiology and Clinical Relevance of Enlarged Perivascular Spaces in the Aging Brain 2022
• Comparison of Clinical Outcomes 1 and 5 Years Post-Injury Following Combat Concussion 2021
• Measuring the Quality of Neurologic Care in the United States 2021
• Opinion & Special Articles: Maximizing Inclusiveness and Diversity Through Virtual Residency Applications and Interviews 2021
• Author response: Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study 2020
• Author response: Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study 2020
• Clinical Reasoning: A 45-year-old man with progressive insomnia and psychiatric and motor symptoms 2020
• Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. 2020
• β-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters. 2020
• Cerebral microbleeds: Prevalence and relationship to amyloid burden 2019
• Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults 2019
• Development of ¹ h mrs biomarkers for tracking early predementia Alzheimer disease 2019
• Dietary patterns during adulthood and cognitive performance in midlife 2019
• Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study 2019
• In vivo ¹⁸ F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms 2018
• Rapid Revascularization of Simultaneous Bilateral ICA Occlusions causing Coma 2018
• Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly 2018
• 1 H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults 2017
• Diagnosis and management of dementia with Lewy bodies 2017
• Ibrutinib monotherapy in relapsed/refractory CNS lymphoma: A retrospective case series. 2017
• Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia 2016
• Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. 2016
• Effects of hormone therapy on brain structure 2016
• Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment 2016
• MR spectroscopy, APOE genotype, and evolving β-amyloid pathology 2016
• Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly. 2016
• A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. 2015
• Antemortem MRI findings associated with microinfarcts at autopsy 2014
• Association of hypometabolism and amyloid levels in aging, normal subjects 2014
• Association of type 2 diabetes with brain atrophy and cognitive impairment 2014
• Dementia with Lewy bodies: Basis of cingulate island sign 2014
• Lesional REM sleep behavior disorder localizes to the dorsomedial pons 2014
• Past hormone therapy in older women: Does the brain recover from adverse effects? 2014
• Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult 2014
• Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker study. 2014
• MRI and MRSpredictors of mild cognitive impairment in a population-based sample 2013
• MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies 2013
• Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies 2013
• Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women 2013
• Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. 2013
• APOE modifies the association between Aβ load and cognition in cognitively normal older adults 2012
• Erratum: Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies (Neurology (2012) 79 (553-560)) 2012
• Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies 2012
• Imaging markers offer promise : Dream enactment may predict your patient's future 2012
• Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease 2012
• Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin 2012
• Diffusion tensor imaging and cognitive function in older adults with no dementia 2011
• Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies 2011
• Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults 2011
• Dementia with Lewy bodies and Alzheimer disease: Neurodegenerative patterns characterized by DTI 2010
• Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia 2010
• MRS in presymptomatic MAPT mutation carriers: A potential biomarker for tau-mediated pathology 2010
• Risk of dementia in MCI: Combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS 2009
• MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study 2008
• Treatment of human myasthenia gravis with oral antisense suppression of acetylcholinesterase. 2007
• DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment 2005
• ¹H MR spectroscopy in common dementias 2004
• Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. 2002

Identity

International Standard Serial Number (ISSN)

• 1526632X